-+ 0.00%
-+ 0.00%
-+ 0.00%

JOHNSON & JOHNSON RECEIVES FDA APPROVAL FOR TRUFILL N‑BCA LIQUID EMBOLIC SYSTEM FOR THE TREATMENT OF SYMPTOMATIC CHRONIC SUBDURAL HEMATOMA

Reuters·12/18/2025 13:00:05

Please log in to view news